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Abstract
Inadvertent lead placement in the left ventricle (LV) is an uncommon and often under-diagnosed 
complication of cardiac device implantation. Thromboembolic (TE) events are common and 
usually secondary to fibrosis or thrombus formation on or around the lead. Anticoagulation can 
prevent TE events. Percutaneous and surgical LV lead extractions have been performed 
successfully, but the risks of percutaneous lead removal are not well-defined. In this report, we 
describe a case of inadvertent LV lead placement and briefly review the contemporary literature.
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Case   Report                                                                                
A 78 year-old man with a history of paroxysmal atrial fibrillation (AF) presented with syncope 
and underwent implantation of a dual-chamber Medtronic KDR703 pacemaker while in AF. A 
Medtronic 4068 ventricular lead was implanted and found to have a threshold of 1.2 Volts (V) at 
0.5 ms, a current of 1.8 milliamps and an impedance of 887 ohms. R-wave sensing was noted to 
be 16.6 mV. A Medtronic 4568 atrial lead was implanted but threshold testing was not 
performed and sensing was not reported. The pacemaker was programmed to VVIR 60-120.    
Two months later, the patient developed left upper extremity weakness and a computed-
tomography (CT) scan confirmed the clinical diagnosis of a right parietal cerebrovascular 
accident (CVA). The CVA was attributed to thromboembolism secondary to AF and the patient 
was initiated on warfarin therapy with a target INR of 2.0-3.0.                                  
The patient was referred to our clinic after his ventricular lead was noted to have low impedance 
and a decrease in sensed R wave amplitude on routine interrogation. The patient's ECG is shown 
(Figure 1). The diagnosis of inappropriate lead placement in the LV was suspected on the basis 
of the paced right bundle branch block (RBBB) pattern noted on this ECG. The diagnosis was 
confirmed by anterior and lateral chest radiography (Figure 2). A non-contrast chest CT scan 
shows the ventricular lead coursing from the right atrium into the left atrium (LA) through an 
atrial septum defect (ASD) (Figure 2).
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Figure 1. 12-lead ECG obtained from a patient with an endocardial LV lead with a RBBB-configuration of the 
stimulated QRS complex.
Figure 2. A. PA and lateral chest radiograph from a patient with inadvertent LV lead placement. The lead in the LV 
is clearly seen posteriorly on the lateral view. B. Chest CT from the same patient. The ventricular lead is seen 
passing from the RA to the LA through an ASD and from the LA to the LV through the mitral valve.
Device interrogation revealed a ventricular lead threshold of 1.25 V at 0.4 ms, R wave sensing of 
2.8-4.0 mV and a lead impedence of 248 ohms. The patient was in AF during interrogation with 
a slow, irregular ventricular response. No atrial capture could be demonstrated and no P waves 
were   sensed.                                                                      
Due to suspected ventricular lead dysfunction and concern that sudden loss of ventricular pacing 
would lead to a recurrence of syncope, the patient underwent lead revision. A St. Jude 1688 lead 
was inserted into the right ventricle under fluoroscopic guidance using anterior and lateral views 
and the existing atrial lead and LV lead were capped. The patient's warfarin dose was increased 
to achieve a target INR of 2.5-3.5. The patient was discharged home without event. At the time 
of this report submission, the patient has had no further TE complications. Given the patient's 
age and comorbidities, should he experience further TE complications despite appropriate 
anticoagulation or if he develops an absolute contraindication to warfarin, we would consider 
percutaneous LV lead extraction with on-site cardiothoracic surgery back-up.                       
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Discussion
Review
Inadvertent  LV pacing   due to  malpositioned  endocardial  pacing  leads  is a known, but 
uncommon complication of permanent pacemaker implantation. A Medline search of English-
language articles revealed over 40 cases of inadvertent LV lead placement. As in our case, 
passage of the lead through an ASD or patent foramen ovale was the most common reported 
cause of inadvertent LV pacing [1,2]. Inadvertent LV pacing has also been described in the 
setting of ventricular septal and apical perforation [3]. Erroneous cannulation of the subclavian 
artery and retrograde passage of the lead into the LV across the aortic valve has also been 
reported   [4].                                                                                              
TE complications occurred in approximately forty percent of patients after inadvertent LV lead 
placement [3,5-7]. Thromboembolism is thought to have resulted from thrombus formation and 
fibrosis on or around the site of lead implantation. Case reports describe syncope, amaurosis 
fugax, aphasia and hemiplegia as the most common presenting complaints of patients with 
thromboembolism [4,6,8]. TE events have been reported as soon as one day after lead 
implantation and up to several years later [3]. Thromboembolism has been described in several 
patients receiving antiplatelet therapy [7]. Other significant complications of inadvertent LV 
lead placement included endocarditis, pericardial effusion, vascular damage and peripheral 
arterial   thrombosis   [7].                                                                          
Time from implantation to diagnosis is highly variable and appears to influence treatment 
strategy. Percutaneous LV lead removal has been successful but only in patients diagnosed less 
than one year after LV lead placement [4,9,10]. Fifty percent of patients with and twenty-five 
percent of patients without TE complications underwent surgical lead removal. Inspection of 
explanted leads showed adherent thrombus in several cases, including those explanted from 
asymptomatic patients and patients receiving aspirin. Notably, transthoracic and transesophageal 
echocardiography failed to identify thrombus preoperatively in several of these cases [7].           
Of patients with inadvertent LV lead placement treated without surgery, only one case of 
anticoagulation failure with warfarin was reported. This event occurred in the setting of a 
subtherapeutic INR (1.6) [3]. Data from 20 patients with intentional endocardial LV lead 
placement for cardiac resynchronization indications were also reviewed for TE complications 
[11,12]. These data also show a low incidence (one patient) of thromboembolism with 
anticoagulation.
Diagnosis
Early activation of the LV during pacing creates a RBBB-pattern on ECG and, as in our case, is 
often the key to diagnosis of inadvertent LV lead placement (Figure 1). This ECG pattern has 
good sensitivity but inadequate specificity for LV lead malposition since a similar pattern may 
be seen in the setting of RV dilatation, septal pacing or coronary sinus pacing [13]. Most patients 
with malpositioned LV leads, as in our case, have normal pacing thresholds and this cannot be 
recommended as a screening tool. As the patient had normal lead impedances on implantation, 
we do not hypothesize that the low impedances noted in our case relate directly to endocardial 
LV lead placement. Chest radiography, in contrast, is often helpful in delineating the position of 
the ventricular lead and can therefore be used a confirmatory test in suspected lead malposition 
(Figure   2).                                                                                  
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It is advisable that all patients undergoing device implantation have a 12-lead ECG recorded 
during pacing. Consideration should also be given to routine post-implantation anterior and 
lateral chest radiography. At a minimum, those with a RBBB-pattern during pacing should 
receive  both  an   anterior   and  lateral   chest radiograph.  If  lead  malposition   is  suspected, 
echocardiography can be helpful in confirming the diagnosis and determining the course of the 
lead but, due to its poor sensitivity in published reports, should not be used to 'rule out' the 
presence of thrombus [4,14].                                                                                           
Management
If a diagnosis of inadvertent lead placement in the LV is made immediately after implant, 
percutaneous lead extraction can reduce the risk of future TE events without the need for 
lifelong   anticoagulation.   While   percutaneous   LV   lead   extraction   has   been   performed 
successfully up to 9 months after implantation, this procedure carries a risk of systemic 
embolization from lead manipulation, especially if a laser sheath is used [9,10]. While thrombus 
formation has occurred in the first 24-48 hours after LV lead implantation, percutaneous lead 
extraction is appealing in this period because it does not require the use of a laser sheath and 
thus may have lower procedural risk than surgical lead removal with use of cardiopulmonary 
bypass.
For those patients in whom the diagnosis of inadvertent LV lead placement is delayed, 
anticoagulation with warfarin is reasonable as no TE events have been reported in patients with 
an INR of 2.5-3.5 [12]. Use of antiplatelet therapy as a sole means of TE prophylaxis in patients 
with inadvertent LV lead placement is not advisable. Surgical LV lead extraction also warrants 
consideration, especially if cardiac surgery has to be performed for another indication. Surgical 
lead extraction may be preferable in younger patients in whom the risk of surgery is lower and 
the planned duration of warfarin longer.                                                                             
Conclusions
While uncommon, inadvertent LV lead placement is a potentially devastating complication of 
pacemaker implantation. Appropriate analysis of the paced QRS pattern on ECG and post-
implantation   chest   radiograph   may   reduce   morbidity   and   mortality   by   promoting   early 
recognition and treatment. Percutaneous lead extraction is an option for patients diagnosed in the 
immediate post-operative period. Surgical lead removal or lifelong anticoagulation should be 
considered for patients in whom the diagnosis of inadvertent LV lead placement is delayed.
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